Mohta M, Aggarwal M, Sethi A K, Harisinghani P, Guleria K
Department of Anaesthesiology and Critical Care, University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi, India.
Department of Anaesthesiology and Critical Care, University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi, India.
Int J Obstet Anesth. 2016 Aug;27:32-40. doi: 10.1016/j.ijoa.2016.02.004. Epub 2016 Feb 21.
Most studies comparing phenylephrine and ephedrine have been conducted during elective caesarean sections in healthy mothers with no fetal compromise. The effect of vasopressors on fetal outcome may differ between healthy and compromised fetuses. There has been little research into the effect of phenylephrine and ephedrine, when used for management of post-spinal hypotension in the presence of potential fetal compromise.
Healthy women with a singleton pregnancy undergoing emergency caesarean section for fetal compromise under spinal anaesthesia were studied. One-hundred-and-six consecutive subjects, who developed hypotension after spinal anaesthesia, were randomly allocated to two groups of 53 each, to receive either phenylephrine (Group P) or ephedrine (Group E). For every systolic blood pressure reading <100mmHg patients received phenylephrine 100μg or ephedrine 8mg depending on group allocation. Umbilical blood gas parameters and Apgar scores were recorded.
There was no statistically significant difference in umbilical arterial pH (P=0.79), umbilical venous pH (P=0.98), other blood gas parameters, incidence of fetal acidosis (P=1.00) and Apgar scores. The number of hypotensive episodes, vasopressor doses for treatment of the first hypotensive episode and the total number of doses used during the study period were comparable. The median [IQR] total number of doses of phenylephrine and ephedrine used before delivery were 2 [1-2] and 2 [1-2], respectively (P=0.67). More patients receiving ephedrine (24.5%) developed tachycardia than those receiving phenylephrine (3.8%) (P=0.004). Bradycardia was more common with phenylephrine, with 39.6% of patients in Group P as compared to only 1.9% of patients in Group E developing a heart rate <60beats/min after vasopressor administration (P=0.001).
Both phenylephrine 100μg and ephedrine 8mg boluses are equally efficacious when treating post-spinal hypotension in the presence of potential fetal compromise. However, phenylephrine may be a better choice in the presence of maternal tachycardia.
大多数比较去氧肾上腺素和麻黄碱的研究是在健康母亲进行择期剖宫产且胎儿无窘迫的情况下进行的。血管升压药对胎儿结局的影响在健康胎儿和有并发症的胎儿之间可能有所不同。对于在存在潜在胎儿窘迫的情况下使用去氧肾上腺素和麻黄碱治疗腰麻后低血压的效果,研究较少。
对在腰麻下因胎儿窘迫行急诊剖宫产的单胎妊娠健康女性进行研究。连续106例腰麻后出现低血压的受试者被随机分为两组,每组53例,分别接受去氧肾上腺素(P组)或麻黄碱(E组)。每次收缩压读数<100mmHg时,根据分组,患者接受100μg去氧肾上腺素或8mg麻黄碱。记录脐血气参数和阿氏评分。
脐动脉pH值(P = 0.79)、脐静脉pH值(P = 0.98)、其他血气参数、胎儿酸中毒发生率(P = 1.00)和阿氏评分无统计学显著差异。低血压发作次数、治疗首次低血压发作的血管升压药剂量以及研究期间使用的总剂量相当。分娩前使用去氧肾上腺素和麻黄碱的总剂量中位数[四分位间距]分别为2[1-2]和2[1-2](P = 0.67)。接受麻黄碱的患者(24.5%)发生心动过速的比例高于接受去氧肾上腺素的患者(3.8%)(P = 0.004)。使用去氧肾上腺素时心动过缓更常见,P组39.6%的患者在使用血管升压药后心率<60次/分钟,而E组仅1.9%的患者出现这种情况(P = 0.001)。
在存在潜在胎儿窘迫的情况下治疗腰麻后低血压时,100μg去氧肾上腺素和8mg麻黄碱推注同样有效。然而,在产妇心动过速的情况下,去氧肾上腺素可能是更好的选择。